Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Highlighting shoulder injury related to vaccine administration

I would like to highlight an important, though rarely discussed or reported, issue: shoulder injury related to vaccine administration (SIRVA). I implore any pharmacists who offer travel or flu vaccinations to take note.

SIRVA is a result of the body’s immune response to direct injection of a vaccine into the shoulder capsule instead of the deltoid muscle.

In summer 2018, I was injected at a pharmacy travel clinic and suffered SIRVA. Even after 12 months, rehabilitation and a steroid injection, it was not completely resolved. Symptoms included considerable pain, inability to use the arm and lack of range/mobility, not to mention many sleepless nights.

I believe — and have the expert opinions of allied healthcare professionals to support this — that I was injected too high (into the shoulder capsule) with too long a needle for my frame size. I have heard of several other similar cases of SIRVA in relation to pharmacist injectors.

My experience led me to research the training that pharmacists are given before they can administer any injections and their required competencies. The ‘National Minimum Standards and Core Curriculum for Immunisation Training for Registered Healthcare Practitioners’[1] sets the standards and lists the essential topics that should be incorporated into training for immunisations in the national schedule, but, as the document states, it “does not set out the processes for commissioning, procuring and delivering training”. SIRVA does not feature in the document, and it is a challenge to find any publicly available information on this topic, possibly owing to under-reporting. And it is difficult to source any publicly available information on training requirements for pharmacists administering travel vaccines.

Several published articles mention SIRVA and link it to a lack of anatomical understanding and inadequate training[2],[3],[4],[5]. In 2018, Bancsi et al. highlighted to pharmacist injectors the risk of SIRVA and provided a useful diagram to help landmark the patient’s arm and a guide for things to watch out for, such as needle length[2].

I call on the profession to review and improve the current training requirements and ensure regular renewal of skills training. With the increase in pharmacy injectors, appropriate injection technique is crucial to avoid SIRVA and uphold the expected standards of the profession.

Pharmacists should not inject patients if they are not completely sure of what they are doing; the consequences of getting it wrong are considerable for the patient and the profession.


Anonymous pharmacist, London

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207155

Readers' comments (1)

  • This is important to bear in mind; thank you.
    In this connection, as a pediatrician I not infrequently witness cases where only by an act of Providence the sciatic nerve escapes injury from an untrained person-phramacist or nurse, or even a physician.

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.